What Happened?
Mountain View, CA-based Curve Biosciences Appointed Nathan Hunkapiller as Chief Technology Officer
About the Company
Curve Biosciences (“Curve”), a company bringing precision to chronic disease care, creates products targeting biological changes in tissues that result in the development and progression of chronic diseases. Curve`s Chronic Disease Tissue Atlas (CDTA) uniquely allows the company to discover these precise changes with data from over 250,000 tissues across more than 1,000 clinical studies. Curve is focused on first commercializing its best-in-class blood tests for the $30 billion market of chronic liver diseases while using CDTA to find biomarkers and targets for other conditions.
About the Person
Nathan Hunkapiller is Chief Technology Officer at Curve Biosciences. Previously, Nathan held various senior IT leadership roles in the industry.
Info Source
News
Short Profile